{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Ketamine: Newer Uses Emerge for an Older Drug
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
NOTE: This activity requires payment before viewing.Purpose of Activity
To review the history of the development and original uses of ketamine and to explore the current and potential advantages and disadvantages of the drug in the management of depression, post-traumatic stress disorder and postoperative pain.Learning Objectives
After completing this continuing education activity you will be able to:
- Explain how ketamine was developed as an anesthetic agent.
- Identify its use in ameliorating postoperative pain.
- Evaluate the potential for treatment or exacerbation of posttraumatic stress disorder.
- List the consensus guidelines for acute pain management.
Disclosures
The author, faculty, and staff in a position to control the content of this CME activity have disclosed that they and their spouses/ life partners (if any) have no financial relationships with, or financial interests in, any commercial companies relevant to this educational activity.
Price:
$49.00
Credits:
- ANCC 1.0 CH / 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: TPM0119
Published: Jan 2019
Expires: 12/31/2026
Sources:
Topics in Pain Management
Required Passing Score: 7/10 (70%)